These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17936161)

  • 1. The truth and consequences of the COURAGE trial.
    Kereiakes DJ; Teirstein PS; Sarembock IJ; Holmes DR; Krucoff MW; O'Neill WW; Waksman R; Williams DO; Popma JJ; Buchbinder M; Mehran R; Meredith IT; Moses JW; Stone GW
    J Am Coll Cardiol; 2007 Oct; 50(16):1598-603. PubMed ID: 17936161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What can be learned from the COURAGE trial?
    Beller GA
    J Nucl Cardiol; 2008; 15(1):1-2. PubMed ID: 18242471
    [No Abstract]   [Full Text] [Related]  

  • 3. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
    Borden WB; Redberg RF; Mushlin AI; Dai D; Kaltenbach LA; Spertus JA
    JAMA; 2011 May; 305(18):1882-9. PubMed ID: 21558519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.
    De Bruyne B; Pijls NH; Kalesan B; Barbato E; Tonino PA; Piroth Z; Jagic N; Möbius-Winkler S; Rioufol G; Witt N; Kala P; MacCarthy P; Engström T; Oldroyd KG; Mavromatis K; Manoharan G; Verlee P; Frobert O; Curzen N; Johnson JB; Jüni P; Fearon WF;
    N Engl J Med; 2012 Sep; 367(11):991-1001. PubMed ID: 22924638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.
    Spertus JA; Maron DJ; Cohen DJ; Kolm P; Hartigan P; Weintraub WS; Berman DS; Teo KK; Shaw LJ; Sedlis SP; Knudtson M; Aslan M; Dada M; Boden WE; Mancini GB;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):409-18. PubMed ID: 23838107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Unstable angina].
    Ibuki C
    Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():234-9. PubMed ID: 17952997
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy.
    Pride YB; Tung P; Mohanavelu S; Zorkun C; Wiviott SD; Antman EM; Giugliano R; Braunwald E; Gibson CM;
    JACC Cardiovasc Interv; 2010 Aug; 3(8):806-11. PubMed ID: 20723851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal medical therapy with or without PCI for stable coronary disease.
    Boden WE; O'Rourke RA; Teo KK; Hartigan PM; Maron DJ; Kostuk WJ; Knudtson M; Dada M; Casperson P; Harris CL; Chaitman BR; Shaw L; Gosselin G; Nawaz S; Title LM; Gau G; Blaustein AS; Booth DC; Bates ER; Spertus JA; Berman DS; Mancini GB; Weintraub WS;
    N Engl J Med; 2007 Apr; 356(15):1503-16. PubMed ID: 17387127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
    Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
    Holper EM; Addo T
    Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
    Maresta A; Balducelli M; Latini R; Bernardi G; Moccetti T; Sosa C; Barlera S; Varani E; Ribeiro da Silva EE; Monici Preti A; Maggioni AP;
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
    Maron DJ; Spertus JA; Mancini GB; Hartigan PM; Sedlis SP; Bates ER; Kostuk WJ; Dada M; Berman DS; Shaw LJ; Chaitman BR; Teo KK; O'Rourke RA; Weintraub WS; Boden WE;
    Am J Cardiol; 2009 Oct; 104(8):1055-62. PubMed ID: 19801024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COURAGE under fire: on the management of stable coronary disease.
    Diamond GA; Kaul S
    J Am Coll Cardiol; 2007 Oct; 50(16):1604-9. PubMed ID: 17936162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial.
    Mancini GB; Bates ER; Maron DJ; Hartigan P; Dada M; Gosselin G; Kostuk W; Sedlis SP; Shaw LJ; Berman DS; Berger PB; Spertus J; Mavromatis K; Knudtson M; Chaitman BR; O'Rourke RA; Weintraub WS; Teo K; Boden WE;
    Circ Cardiovasc Qual Outcomes; 2009 Jul; 2(4):320-7. PubMed ID: 20031857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial.
    Erne P; Schoenenberger AW; Burckhardt D; Zuber M; Kiowski W; Buser PT; Dubach P; Resink TJ; Pfisterer M
    JAMA; 2007 May; 297(18):1985-91. PubMed ID: 17488963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early aggressive treatment of unstable angina without on-site cardiac surgical facilities: a prospective study of acute and long-term outcome.
    Ferrero V; Steffenino G; Meinardi F; Conte E; Deorsola A; Vado A; Racca E; Dellavalle A; Ribichini F; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Feb; 28(2):112-9. PubMed ID: 9534050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
    Werner GS; Martin-Yuste V; Hildick-Smith D; Boudou N; Sianos G; Gelev V; Rumoroso JR; Erglis A; Christiansen EH; Escaned J; di Mario C; Hovasse T; Teruel L; Bufe A; Lauer B; Bogaerts K; Goicolea J; Spratt JC; Gershlick AH; Galassi AR; Louvard Y;
    Eur Heart J; 2018 Jul; 39(26):2484-2493. PubMed ID: 29722796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
    Shaw LJ; Berman DS; Maron DJ; Mancini GB; Hayes SW; Hartigan PM; Weintraub WS; O'Rourke RA; Dada M; Spertus JA; Chaitman BR; Friedman J; Slomka P; Heller GV; Germano G; Gosselin G; Berger P; Kostuk WJ; Schwartz RG; Knudtson M; Veledar E; Bates ER; McCallister B; Teo KK; Boden WE;
    Circulation; 2008 Mar; 117(10):1283-91. PubMed ID: 18268144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial.
    Rajagopal V; Lincoff AM; Cohen DJ; Gurm HS; Hu T; Desmet WJ; Kleiman NS; Bittl JA; Feit F; Topol EJ
    Am Heart J; 2006 Jul; 152(1):149-54. PubMed ID: 16824845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
    Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.